It was reported to boston scientific corporation that a upsylon y-mesh was implanted into the patient on (b)(6) 2000.The patient experienced complications, further surgery, and nonsurgical treatment.Patient symptoms include: back pain; vaginal pain; pelvic pain; painful intercourse; incontinence not present before implant.Surgical interventions: on (b)(6) 2009 the patient underwent further surgery regarding the upsylon y-mesh implant under general anesthesia for the following purpose: cystocele.Nonsurgical treatments: on (b)(6) 2013 the patient commenced incontinence medication: vegiferm for purpose: to keep pain away.Treatment duration: forever.On (b)(6) 2013 the patient commenced topical treatment (including oestrogen cream): troches for purpose: to keep hormones working.On (b)(6) 2017 the patient commenced injections (not associated with surgical treatment): botox for the urgency for purpose: to stop going to the toilet too often.
|
(b)(6).The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The upn provided was chosen as a representative upn to capture the implanted device.The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|